Nanomedicine: Nanotechnology, Biology and Medicine
Volume 1, Issue 1 , Pages 47-51 , March 2005

The pathway to commercialization for nanomedicine

  • Ted Flynn, MPA

      Affiliations

    • Potomac Investment Capital, LLC, Sterling, Virginia
    • ,
  • Chiming Wei, MD, PhD

      Affiliations

    • Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Corresponding Author InformationCorresponding author. 600 N Wolfe St/Blalock 1206, Baltimore, MD 21205.

Received 2 October 2004 ,Accepted 23 November 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1549-9634(05)00013-4

doi: 10.1016/j.nano.2004.11.010

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 1, Issue 1 , Pages 47-51 , March 2005

Article Tools

* Image Usage & Resolution